Nanoparticle News and Research

RSS
An innovative nasal vaccine strategy to combat COVID

An innovative nasal vaccine strategy to combat COVID

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and  COVID-19 vaccination

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination

OSU researchers take major step toward improving, lengthening the lives of cystic fibrosis patients

OSU researchers take major step toward improving, lengthening the lives of cystic fibrosis patients

Advanced type of nanoparticle could help fight hard-to-treat cancers

Advanced type of nanoparticle could help fight hard-to-treat cancers

Collaborative research paves a new way to better health for patients with enlarged hearts

Collaborative research paves a new way to better health for patients with enlarged hearts

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

Transition in the management of COVID-19

Transition in the management of COVID-19

Silver nanoparticle and polyurethane composite provides potential coating options to limit fomite transmission of SARS-CoV-2

Silver nanoparticle and polyurethane composite provides potential coating options to limit fomite transmission of SARS-CoV-2

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Key biophysical attributes of a self-amplifying viral RNA vaccine developed for SARS-CoV-2

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

Research may lead to safer ways to care for patients impacted by blood clots

Research may lead to safer ways to care for patients impacted by blood clots

Brain stimulation combined with nasal spray containing nanoparticles can improve stroke recovery

Brain stimulation combined with nasal spray containing nanoparticles can improve stroke recovery

Novel nanozyme protects bones against damage from radiation

Novel nanozyme protects bones against damage from radiation

Deep mutational scanning for SARS-CoV-2 Omicron BA.1 and BA.2 subvariants

Deep mutational scanning for SARS-CoV-2 Omicron BA.1 and BA.2 subvariants

Endogenous exosomes act as decoys for SARS-CoV-2

Endogenous exosomes act as decoys for SARS-CoV-2

An improved COVID-19 vaccine shows promise against Omicron in experimental models

An improved COVID-19 vaccine shows promise against Omicron in experimental models

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.